Acquisition by Silverman Joshua of 200000 shares of MyMD Pharmaceuticals at 1.66 subject to Rule 16b-3
MYMDDelisted Stock | USD 1.82 0.02 1.09% |
About 61% of MYMD Old's investor base is looking to short. The analysis of current outlook of investing in MYMD Old suggests that many traders are alarmed regarding MYMD Old's prospects. The current market sentiment, together with MYMD Old's historical and current headlines, can help investors time the market. In addition, many technical investors use MYMD Old stock news signals to limit their universe of possible portfolio assets.
MYMD |
Filed transaction by MyMD Pharmaceuticals Director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
MYMD Old Fundamental Analysis
We analyze MYMD Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MYMD Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MYMD Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
MYMD Old is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
MYMD Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MYMD Old stock to make a market-neutral strategy. Peer analysis of MYMD Old could also be used in its relative valuation, which is a method of valuing MYMD Old by comparing valuation metrics with similar companies.
Peers
MYMD Old Related Equities
NBY | NovaBay Pharmaceuticals | 6.35 | ||||
RXRX | Recursion Pharmaceuticals | 4.97 | ||||
GOSS | Gossamer Bio | 3.13 | ||||
UBX | Unity Biotechnology | 2.76 | ||||
REPL | Replimune | 1.97 | ||||
XBIO | Xenetic Biosciences | 1.72 | ||||
AVIR | Atea Pharmaceuticals | 1.71 | ||||
LYRA | Lyra Therapeutics | 0.00 | ||||
KZR | Kezar Life | 0.31 | ||||
LGND | Ligand Pharmaceuticals | 1.13 | ||||
SRZN | Surrozen | 1.28 | ||||
REVB | Revelation Biosciences | 1.31 | ||||
KROS | Keros Therapeutics | 1.38 | ||||
NVCT | Nuvectis Pharma | 1.46 | ||||
LYEL | Lyell Immunopharma | 1.67 | ||||
PASG | Passage Bio | 1.69 | ||||
BOLT | Bolt Biotherapeutics | 2.00 | ||||
DSGN | Design Therapeutics | 2.61 | ||||
KRON | Kronos Bio | 2.88 | ||||
ORIC | Oric Pharmaceuticals | 3.16 | ||||
LRMR | Larimar Therapeutics | 4.71 | ||||
GOVX | GeoVax Labs | 4.98 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in MYMD Stock
If you are still planning to invest in MYMD Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MYMD Old's history and understand the potential risks before investing.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |